Home » Topics » Regulatory

Regulatory
RSS

European Commission approves Qutenza for peripheral neuropathic pain

May 22, 2009

FDA approves UCB's pegylated anti-TNF Cimzia for rheumatoid arthritis

May 14, 2009

FDA grants marketing approval to Vanda's Fanapt for schizophrenia

May 7, 2009

FDA approves Novartis' combination drug Exforge HCT for high blood pressure

May 4, 2009

Once-daily antiepileptic Zebinix approved in the European Union

April 28, 2009

European Commission grants Wyeth marketing authorization for Conbriza

April 28, 2009

Ajinomoto and Dainippon granted approval for additional indication for Niflec and Gasmotin

April 27, 2009

European Commission approves Removab for malignant ascites

April 24, 2009

Simponi approved for RA, psoriatic arthritis and ankylosing spondylitis

April 14, 2009

FDA approves Afinitor in patients with advanced kidney cancer

March 31, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.